AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimitel-M Tablet ER

Prescription Icon
Prescription Required

Marketer

L T & L Pharma Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimitel-M Tablet ER

Diabex Duo ER tablets are classified as antidiabetic medications, combining two active ingredients to manage type 2 diabetes in adults. This dual-action formulation helps regulate blood glucose. Diabex Duo ER should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose, increasing the risk of complications like kidney impairment, vision loss, neuropathy, and limb amputation. Remember, this medication complements a comprehensive treatment plan encompassing a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices are critical in diabetes management. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms such as sweating, lightheadedness, headache, and tremors. Learn to recognize and treat these symptoms; maintain regular meals and carry a fast-acting glucose source like sugary snacks or juice. Alcohol consumption increases hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain is also possible. Diabex Duo ER is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Individuals with a history of heart disease should consult their physician before commencing treatment. Pregnant or breastfeeding individuals should seek medical advice prior to use. Regular blood glucose monitoring is essential, along with potential blood tests to track blood cell counts and liver function.

Uses of Glimitel-M Tablet ER

Managing Type 2 Diabetes

Major Benefits of Glimitel-M Tablet ER:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. It's recommended to take Glimitel-M Tablet ER with a meal.

Common Side effects of Glimitel-M Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimitel-M Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; do not chew, crush, or divide it. Glimitel-M Extended-Release Tablets should be taken with a meal.

How Glimitel-M Tablet ER works:

Glimitel-M Extended-Release tablets contain glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, enhances insulin secretion from the pancreas, thus reducing blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and improving insulin responsiveness in the body.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Glimitel-M Tablet ER and alcohol is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Glimitel-M tablets may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimitel-M tablets are contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Glimitel-M Extended-Release Tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Glimitel-M Extended-Release Tablet use. Physician consultation is essential. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Glimitel-M Tablet ER to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician. A reduced initial dose of Glimitel-M Tablet ER is typically recommended for patients with mild to moderate liver disease; its administration is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Glimitel-M Tablet ER :

Should you forget a dose of Glimitel-M Extended-Release Tablet, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimitel-M Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimitel-M Tablet ER

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimitel-M Tablet ER can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA—Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimitel-M Tablet ER and seek immediate medical attention.
Glimitel-M ER tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glimitel-M Tablet ER may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Glimitel-M Tablet ER use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, supplemental vitamin B12 is recommended annually by some researchers.
Glimitel-M ER tablets can cause low blood sugar (hypoglycemia), characterized by nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimitel-M ER tablets and alcohol is unsafe. Alcohol can worsen Glimitel-M's blood sugar-lowering effect, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Glimitel-M Tablet ER
67
MRP 77
12% off